Cite
HARVARD Citation
Necchi, A. et al. (n.d.). 905PDMultiple-cohort analysis investigating FGFR3 alteration as a predictor of non-response to neoadjuvant pembrolizumab (pembro) in muscle-invasive bladder cancer (MIBC). Annals of oncology. p. . [Online].